- News
News
Self-eating rocket could help UK take a big bite of space industry
New developments on a nearly century-old concept for a ‘self-eating’ rocket engine capable of flight beyond the Earth’s atmosphere could help the UK take a bigger bite of the space industry.
More
- News
News
Glasgow AI-powered X-ray for earlier detection of lung cancer
An AI-enhanced chest X-ray reporting solution has begun trials in NHS Greater Glasgow and Clyde with the aim of improving early detection of lung cancer.
More
- News
News
University of Glasgow launches Glasgow Centre for Sustainable Energy
The University of Glasgow is launching a new research centre focused on supporting the global transition to sustainable, low-carbon energy systems.
More
- News
News
Multi-million-pound funding boost for medical device innovation in Scotland
Researchers from the James Watt School of Engineering have welcomed news that a medical device consortium supported by the University of Glasgow has secured significant new funding.
More
- News
News
University of Glasgow unveils memorial to Adam Smith
The University of Glasgow has unveiled Glasgow's first memorial to Adam Smith, located at the original site of its Old College.
More
- News
News
Glasgow academic vows the create tech unicorn
Lee Cronin is not your typical academic, even though he occupies the regius chair for chemistry at the University of Glasgow. He brims with self-confidence, swagger even, that is both beguiling and redolent of a man on a mission. 
More
- News
News
Glasgow School of Art co-launches Creative Founders Fund 
The Glasgow School of Art is delighted to co-launch the Creative Founders Fund on Tuesday 21 of November at the Adam Smith Business School, University of Glasgow. This new fund is a collaboration between GSA, University of Glasgow and the Royal Conservatoire of Scotland.
More
- News
News
Glasgow-based Glox Therapeutics secures £4m funding to develop precision antimicrobials
Glox Therapeutics, a spin-out company from the Universities of Glasgow and Oxford pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
More